Anavex Life Sciences Corp (AVXL)

[hnbadger1]

WASHINGTON, July 27 (Reuters) - The U.S.
Justice Department has opened a criminal
investigation into Cassava Sciences Inc involving
whether the biotech company manipulated
research results for its experimental Alzheimer's
drug, two people familiar with the inquiry said.
The Justice Department personnel conducting the
investigation into Austin, Texas-based Cassava
specialize in examining whether companies or
individuals have misled or defrauded investors,
government agencies or consumers, according to
the sources, who spoke on condition of anonymity.
The sources did not provide details of the focus of
the probe and whether the department was looking
into any specific individuals.
As in any Justice Department investigation, this
one could lead to criminal charges or be closed
without any charges being brought.